HPLC-DAD Methods for Studying the Stability of Solutions Containing Hydromorphone, Ketorolac, Haloperidol, Midazolam, Famotidine, Metoclopramide, Dimenhydrinate, and Scopolamine

Journal of Liquid Chromatography and Related Technologies

Volumn 26, Issue 17, 2003, Pages 2909-2929

  Nassr, S ^a   Dubue, M C ^b   Lavoie, P ^c   Brazier, J L ^b  

^a Aegera Therapeutics   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HÉMA QUÉBEC   (Canada)

Author keywords

Dimenhydrinate; Famotidine; Haloperidol; HPLC DAD; Hydromorphone; Ketorolac; Metoclopramide; Midazolan; Scopolamine

Indexed keywords

CONCENTRATION (PROCESS); DRUG DOSAGE; DRUG PRODUCTS; SOLUTIONS; THERMODYNAMIC STABILITY;

DRUG MIXTURES;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTIEMETIC AGENT; DIMENHYDRINATE; FAMOTIDINE; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROMORPHONE; KETOROLAC; METOCLOPRAMIDE; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; SCOPOLAMINE;

ANALYTIC METHOD; ARTICLE; CALIBRATION; CANCER PAIN; CANCER PALLIATIVE THERAPY; CHEMOTHERAPY INDUCED EMESIS; DIODE; DIODE ARRAY DETECTOR; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; ULTRAVIOLET SPECTROSCOPY;

EMESIS;

EID: 0242353756     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120025053     Document Type: Article

References (13)

1. Tortorice, P.V.; O'Connell, M.B. Management of chemotherapy-induced nausea and vomiting. Pharmacotherapy 1990, 10, 129-145.
2. Walsh, D.; Doona, M.; Molnar, M.; Lipnickey, V. Symptom control in advanced cancer:. important drugs and routes of administration. Sem. Oncol. 2000, 27, 69-83.
3. Ashbrun, M.A.; Lipman, A.G. Management of pain in the cancer patient. Anesth. Analg. 1993, 76, 402-416.
4. Levy, M.H. Pharmacologic treatment of cancer pain. N. Engl. J. Med. 1996, 335, 1124-1132.
5. Markman, M.; Kennedy, A.; Webster, K.; Peterson, G.; Kulp, B.; Belinson, J. The atiemetic eficacy of oral ondacetron plus intravenious dexamethasone in patients With gynecologic malignancies receiving carboplatine based chemiotherapy. Gynecol. Oncol. 2000, 78, 43-46.
6. Stiles, M.L.; Allen, L.V.; Prince, S.J. Stability of deferoxamine mesylate, floxuridine, fluorouacil, hydromrophone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Am. J. Health-Syst. Pharm. 1996, 53, 1583-1588.
7. Das Dupta, V.; Stewart, K.R. Stability of haloperidol in 5% dextrose injection. Am. J. Hosp. Pharm. 1982, 39, 292-294.
8. Zhang, Y.; Trissel, L.A.; Martinez, J.F.; Gilbert, D.L. Stability of metoclopramide, hydrochloride in plastic syringes. Am. J. Health-Syst. Pharm. 1996, 53, 1300-1302.
9. Shea, B.F.; Souney, P.F. Stability of famotidine frozen in polypropylene syringes. J. Hosp. Pharm. 1990, 47, 2073-2074.
10. Keyi, X.; Gagnon, N.; Bisson, C.; Desmarais, M.; LeBel, M. Stability of famotidine in polypropyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs. Ann. Pharmacother. 1993, 27, 422-426.
11. Bullock, L.; Fitzgerald, J.F.; Glick, M.R.; Parks, R.B.; Schnabel, J.G.; Hancock, B.G. Stability of famotidine 20 and 40 mg/L and amino acids in a total parenteral nutrient solution. Am. J. Hosp. Pharm. 1989, 46, 2321-2325.
12. Vermeire, A.; Remon, J.P. Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone. Int. J. Pharm. 1999, 177, 53-67.
13. Harris, D.C. Quantitative Chemical Analysis, 4th Ed.; W.H. Freeman and Company: New York, 1995; 577-579.